HeartSciences (NASDAQ:HSCS – Get Free Report) and Mitesco (OTCMKTS:MITI – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, risk, dividends and valuation.
Insider & Institutional Ownership
17.2% of HeartSciences shares are held by institutional investors. Comparatively, 0.0% of Mitesco shares are held by institutional investors. 4.9% of HeartSciences shares are held by insiders. Comparatively, 4.9% of Mitesco shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Risk and Volatility
HeartSciences has a beta of 2.44, meaning that its share price is 144% more volatile than the S&P 500. Comparatively, Mitesco has a beta of 5.6, meaning that its share price is 460% more volatile than the S&P 500.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| HeartSciences | N/A | -333.50% | -140.18% |
| Mitesco | -7,638.20% | -2.18% | 303.55% |
Earnings and Valuation
This table compares HeartSciences and Mitesco”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| HeartSciences | $8,669.00 | 753.17 | -$8.77 million | ($4.94) | -0.41 |
| Mitesco | $40,000.00 | 55.62 | $500,000.00 | ($0.36) | -0.30 |
Mitesco has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings for HeartSciences and Mitesco, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| HeartSciences | 1 | 0 | 1 | 0 | 2.00 |
| Mitesco | 0 | 0 | 0 | 0 | 0.00 |
HeartSciences currently has a consensus price target of $8.00, indicating a potential upside of 290.24%. Given HeartSciences’ stronger consensus rating and higher possible upside, equities analysts plainly believe HeartSciences is more favorable than Mitesco.
Summary
Mitesco beats HeartSciences on 7 of the 13 factors compared between the two stocks.
About HeartSciences
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
About Mitesco
Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.
Receive News & Ratings for HeartSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartSciences and related companies with MarketBeat.com's FREE daily email newsletter.
